CHEMICAL BIOLOGY CONSORTIUM

The NCI Chemical Biology Consortium (CBC) was recently established to facilitate the discovery and development of new agents to treat cancer. The Consortium brings together chemical biologists and molecular oncologists from government, industry, and academia to address unmet needs in therapeutic oncology. Through the CBC and the interactions among the various Participants, the NCI's drug discovery and development pipeline can be active from target identification through proof-of-concept clinical trials.

Current members of the CBC are:

• Sanford-Burnham Center for Chemical Genomics
• Emory Chemical Biology Discovery Center
• University of California-San Francisco Fragment Discovery Center
• Georgetown University Medical Center
• The NIH Chemical Genomics Center
• North Carolina Comprehensive Chemical Biology Center
• Southern Research Institute
• SRI International
• University of Minnesota Chemical Diversity Center
• The University of Pittsburgh Chemical Diversity Center
• University of Pittsburgh Specialized Application Center
• Vanderbilt Chemical Diversity Center